← FDA Drug Approvals (Drugs@FDA)

ARGATROBAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CAPLIN · Approved 2021-01-21

Drug application

FDA Application #
ANDA214235
Application type
Abbreviated New Drug Application (Generic)
Brand name
ARGATROBAN
Generic name
ARGATROBAN
Active ingredients
ARGATROBAN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
CAPLIN
Manufacturer
Fresenius Kabi USA, LLC
First approval
2021-01-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown